Search Results for: covid

Part of the vaccinated will lose a valid covid certificate ?
| | |

Part of the vaccinated will lose a valid covid certificate ?

The validity of EU covid certificates given after vaccination in the basic scheme, following a booster, and booster dosage will be lowered to 270 days from 1 February, 2022, according to a press statement from the Ministry of Health. This implies that anyone who completed the basic vaccination cycle in the first four months of…

Will it be impossible to refuse a covid test ordered by an employer? 
|

Will it be impossible to refuse a covid test ordered by an employer? 

According to Minister of Health Adam Niedzielski, a subordinate will not be permitted to refuse an employer-ordered test. He further stated that if the company orders a test, the person will not be sent to quarantine. The project that will allow companies to test employees, according to the Minister of Health, is a compromise solution….

Paxlovid approved as first oral drug for COVID-19
| |

Paxlovid approved as first oral drug for COVID-19

Paxlovid, a Pfizer-developed anti-covid medicine that is the first anti-covid treatment licensed in the United States in oral tablet form, received emergency approval from the US Food and Drug Administration (FDA). Paxlovid was licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA) in London shortly after. The first supply of the medication recently arrived…

Works on the Polish vaccine against COVID-19 are underway ?
| | | | |

Works on the Polish vaccine against COVID-19 are underway ?

Celon Pharma has secured a contract with the Medical Research Agency for the execution and finance of a commercial clinical trial project called “TransformRNA – mRNA Therapeutics generation platform” to create breakthrough therapeutic solutions using RNA technology. The project’s overall cost is PLN 141.6 million, with co-financing totaling approximately PLN 83.5m. As part of the…

COVID-19: restrictions extended until 31 January ?
| |

COVID-19: restrictions extended until 31 January ?

The government’s list of legislative works included a draft of the covid regulation. It expects that the limits will be further tightened and extended until the end of January 2022. There will also be certain modifications that the Ministry of Health has not yet notified the public about. The document confirms the extension of the existing and…

Regulatory changes: mandatory testing for COVID-19 sufferers’ household members and vaccinations for three occupational groups
|

Regulatory changes: mandatory testing for COVID-19 sufferers’ household members and vaccinations for three occupational groups

The Minister of Health has announced new measures to combat the pandemic and tighten restrictions. These include mandatory testing for household members of people with COVID-19, regardless of their covid certification, mandatory vaccination for three occupational groups, and the right to check coronavirus tests by employers. The latest steps to battle the pandemic, according to…

Pfizer increases Paxlovid production capacity after Merck’s COVID tablet suffered unexpected effectiveness setback
| |

Pfizer increases Paxlovid production capacity after Merck’s COVID tablet suffered unexpected effectiveness setback

The effectiveness statistics for Pfizer’s oral COVID-19 medicine are now so promising that the Big Pharma giant is ramping up production even before the FDA issues an emergency use license. Paxlovid will now be produced in the amount of 80 million courses by the end of 2022 an increase from the originally planned 50 million…

Omicron: will there be restrictions due to the new Covid-19 variant?
|

Omicron: will there be restrictions due to the new Covid-19 variant?

Although the Minister of Health talks about reaching the moment of solstice of the fourth wave of Covid-19 infections, the epidemic situation in Poland does not inspire any optimism. Hospitals are already fully occupied and the growing number of infected people requiring hospitalisation is steadily increasing. More wards with covid beds are already opening. However,…

Paxlovid: new drug for COVID-19 undergoes clinical trials
| |

Paxlovid: new drug for COVID-19 undergoes clinical trials

Clinical trials on the efficacy of a novel COVID-19 drug Paxlovid will enlist 90 participants. Pfizer, a pharmaceutical corporation based in the United States, has been granted permission by Russian authorities to test Paxlovid. The medicine will be studied in Russia until March 2023, although it is known that roughly 7,000 people in other countries have already begun…

Paxlovid: Pfizer drug has 89% efficacy against Covid-19
| |

Paxlovid: Pfizer drug has 89% efficacy against Covid-19

Preliminary results from an experimental study of Pfizer’s new drug for Covid-19 are very promising, with an 89% efficacy rate in reducing the risk of hospitalisation and death. This follows a product from Merck that will reduce risk among patients predisposed to a severe form of Covid-19. During ongoing clinical trials of Paxlovid, the drug…